The 10 biggest VC-backed acquisitions of 2012
December 28, 2012 6:30 pm
July 9-10, 2013 San Francisco, CA Tickets On Sale Now While 2012 saw some spectacularly large IPOs like Facebook and… Continue reading ⟩
Funding Daily: An Indian mafia don, his daughter, and some funding news
October 11, 2012 12:52 am
July 9-10, 2013 San Francisco, CA Tickets On Sale Now I struggled with inspiration for today’s theme, and did what… Continue reading ⟩
Longitude Capital pools money for drugs
October 10, 2012 8:41 pm
July 9-10, 2013 San Francisco, CA Tickets On Sale Now Longitude Capital amassed $385 million to invest in drug development and… Continue reading ⟩
Life sciences briefing: Thursday, Oct. 18, 2007
October 18, 2007 2:19 pm
Featured companies: American Oriental Bioengineering, Guangxi Boke, Inspired Technologies, Nanosphere, Patton Medical Devices UPDATED: Expanded items on Nanosphere and Patton… Continue reading ⟩
Biotech financing: Will ImaRx break the IPO slump?
July 26, 2007 4:14 pm
(UPDATED: See below.) It’s been a long, barren summer for biotech IPOs, but ImaRx, the blood-clot company we featured here,… Continue reading ⟩
Nuon Therapeutics: A transplanted company tries to teach an old drug new tricks
July 21, 2007 12:50 am
At a first glance, San Francisco’s Nuon Therapeutics looks like any other specialty-pharmaceutical company that aims to pick up cast-off… Continue reading ⟩
MicuRx raises $10M for new anti-infectives
June 26, 2007 11:25 am
MicuRx Pharmaceuticals, a Union City, Calif., developer of new anti-infective drugs, raised $10 million in a first round of funding.… Continue reading ⟩
MAP Pharma charts course for $86M IPO
June 19, 2007 3:58 pm
MAP Pharmaceuticals, a Mountain View, Calif., developer of reformulated drugs for inhalation, filed to raise up to $86 million in… Continue reading ⟩
Jazz Pharma takes it on the chin, raises less-than-expected $108M in IPO
June 1, 2007 1:15 am
Reuters is reporting that Jazz Pharmaceuticals, maker of the controversial drug Xyrem, priced its six million IPO shares at $18… Continue reading ⟩
Jazz slashes expected IPO price, follows "date rape" controversy
May 31, 2007 4:02 pm
Jazz Pharmaceuticals, the generally unexciting specialty-pharmaceutical maker that hoped to raise $179.4 million in an IPO, has collided with reality.… Continue reading ⟩